Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line
- PMID: 10332049
- DOI: 10.1016/s0168-3659(98)00186-2
Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line
Abstract
The influence of free and N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-bound adriamycin (ADR) on the induction of multidrug resistance in the A2780 human ovarian carcinoma cell line was studied in vitro. It was found that chronic exposure to free ADR led to an increase in resistance to ADR and Taxol and overexpression of the MDR1 gene. No significant changes in the expression of the MRP gene were found during adaptation to free ADR. In addition to MDR1 gene-encoded multidrug resistance, a significant increase in the resistance against ADR was found before the overexpression of the MDR1 gene was measurable. This non-P-glycoprotein resistance does not appear to be connected with MRP gene-encoded resistance. During adaptation to free ADR, changes in cellular metabolism such as increased rate of glucose uptake, oxidation and glycolysis were detected. Adapted sensitive A2780 cells expressed the MDR1 gene and possessed almost the same decreased sensitivity toward ADR as the ADR-resistant human ovarian carcinoma A2780/AD cells. However, they significantly differed in proliferation rate, cellular metabolism and MRP gene expression. On the contrary, multidrug resistance was not induced after repeated exposure of sensitive A2780 cells to HPMA copolymer-bound adriamycin. The cells did not express the MDR1 gene, the expression of the MRP gene was partially inhibited, and the resistance against Taxol was decreased. Differences were also observed in metabolic changes. In summary, the data indicate that, contrary to free ADR, HPMA copolymer-bound ADR does not induce multidrug resistance in A2780 cell culture after repeated exposure.
Similar articles
-
HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.J Control Release. 1998 Jul 31;54(2):223-33. doi: 10.1016/s0168-3659(98)00009-1. J Control Release. 1998. PMID: 9724909
-
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.Eur J Pharm Biopharm. 2000 Jan;49(1):11-5. doi: 10.1016/s0939-6411(99)00033-8. Eur J Pharm Biopharm. 2000. PMID: 10613922
-
Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.Pharm Res. 1999 Jul;16(7):986-96. doi: 10.1023/a:1018959029186. Pharm Res. 1999. PMID: 10450921
-
Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance.Biomaterials. 2000 Nov;21(21):2203-10. doi: 10.1016/s0142-9612(00)00161-7. Biomaterials. 2000. PMID: 10985494
-
Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.Int J Oncol. 1999 Jul;15(1):5-16. doi: 10.3892/ijo.15.1.5. Int J Oncol. 1999. PMID: 10375588
Cited by
-
Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.Nanomedicine (Lond). 2008 Dec;3(6):761-76. doi: 10.2217/17435889.3.6.761. Nanomedicine (Lond). 2008. PMID: 19025451 Free PMC article.
-
Polymer-drug conjugates: origins, progress to date and future directions.Adv Drug Deliv Rev. 2013 Jan;65(1):49-59. doi: 10.1016/j.addr.2012.10.014. Epub 2012 Nov 2. Adv Drug Deliv Rev. 2013. PMID: 23123294 Free PMC article. Review.
-
Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer.Small. 2024 Oct;20(41):e2307462. doi: 10.1002/smll.202307462. Epub 2024 Feb 11. Small. 2024. PMID: 38342698
-
AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry.Cardiovasc Intervent Radiol. 2013 Feb;36(1):198-203. doi: 10.1007/s00270-012-0466-1. Epub 2012 Aug 25. Cardiovasc Intervent Radiol. 2013. PMID: 22923329 Free PMC article.
-
The influence of cytotoxicity of macromolecules and of VEGF gene modulated vascular permeability on the enhanced permeability and retention effect in resistant solid tumors.Pharm Res. 2000 May;17(5):505-14. doi: 10.1023/a:1007500412442. Pharm Res. 2000. PMID: 10888300
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials